In a first, US scientists from Arizona State University (ASU) have developed a plant-based Zika vaccine that could be more potent, safer and cheaper to produce than other medicines being developed for the disease.
The vaccine, developed using tobacco plant, targets a key protein -- called DIII -- which envelopes the outside of the Zika virus and plays a key role for the virus to infect people.By developing this protein without the dangerous virus within it, it could be used to immunise people to the real strain of Zika.
Immunisation experiments on mice showed a 100 per cent success in inducing antibody and cellular immune response to protect against multiple Zika virus strains.
The worldwide Zika threat first emerged in 2015, infecting millions as it swept across the countries and led to the birth of babies with severe brain birth defects.